Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EMA to finalize trial data disclosure policy in June

This article was originally published in Scrip

Executive Summary

In an attempt to assuage industry's fears about the disclosure of commercially confidential information, the European Medicines Agency is looking at the best way of deleting such information before releasing clinical trial data under its controversial draft policy on proactive disclosure. It says it plans to present the final policy together with an implementation plan to its management board for endorsement at its next meeting in June.

Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC024839

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel